Monte Rosa Therapeutics Competitors and Similar CompaniesClear all

Monte Rosa Therapeutics's competitors and similar companies include DNAtriX, Tizona Therapeutics, PIC Therapeutics and Actym Therapeutics.

	Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.	DNAtriX DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.	Tizona Therapeutics Tizona Therapeutics is harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases.	PIC Therapeutics PIC Therapeutics is a biotechnology company.	Actym Therapeutics Actym Therapeutics is a preclinical immuno-oncology company.
Founding Date	Founding Date 2018	Founding Date 2005	Founding Date 2014	Founding Date 2018	Founding Date 2017
Type	Type Public	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare biotech healthtech oncology platform therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech healthtech oncology therapy	Tags Healthcare biotech healthtech oncology therapy	Tags Healthcare biotech healthtech oncology therapy
Locations	Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US	Locations Houston, US HQ San Diego, US	Locations South San Francisco, US HQ	Locations Natick, US HQ	Locations Berkeley, US HQ
Employees	Employees 75	Employees 3	Employees 24	Employees 7	Employees 11
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 15.5m (over 7 years ago)	Latest funding round $ 43m (about 10 years ago)	Latest funding round $ 5m (about 6 years ago)	Latest funding round $ 34m (about 6 years ago)
Total funding raised	Total funding raised $ 223.5m	Total funding raised $ 54.2m	Total funding raised $ 70m	Total funding raised $ 5m	Total funding raised $ 34m